Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
2.150
+0.020 (0.94%)
At close: Oct 3, 2025, 4:00 PM EDT
2.160
+0.010 (0.47%)
After-hours: Oct 3, 2025, 7:59 PM EDT
Biomea Fusion Employees
Biomea Fusion had 106 employees as of December 31, 2024. The number of employees increased by 3 or 2.91% compared to the previous year.
Employees
106
Change (1Y)
3
Growth (1Y)
2.91%
Revenue / Employee
n/a
Profits / Employee
-$1,057,462
Market Cap
127.94M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 106 | 3 | 2.91% |
| Dec 31, 2023 | 103 | 20 | 24.10% |
| Dec 31, 2022 | 83 | 32 | 62.75% |
| Dec 31, 2021 | 51 | 39 | 325.00% |
| Dec 31, 2020 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BMEA News
- 4 days ago - Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update - GlobeNewsWire
- 2 months ago - Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 2 months ago - Biomea Fusion Appoints Julianne Averill to its Board of Directors - GlobeNewsWire
- 3 months ago - Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewsWire
- 3 months ago - Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates - GlobeNewsWire
- 3 months ago - Biomea Fusion Shares Fall After Pricing Underwritten Public Offering - Market Watch
- 3 months ago - Biomea Fusion Announces Pricing of Public Offering of Securities - GlobeNewsWire